The global market for Allergy Diagnostics is projected to reach US$6.4 billion by 2025

driven by the rise in allergies across all age groups. Several reasons have been theorized for this rise including global warming. The rise in temperatures is extending the growing season for plants resulting in increased pollen in the air, a chief cause for respiratory allergies.

| Source: ReportLinker ReportLinker

New York, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Allergy Diagnostics Industry" - https://www.reportlinker.com/p05797875/?utm_source=GNW
Hygiene hypothesis is presented as another reason where excessive focus on cleanliness and increased use of sanitizers and disinfectants is reducing exposure to bacteria and viruses which in reality is vital in training the immune system to fight infections. The result is the development of an immune system untaught by infections and parasites to recognize real threats. Children and adults therefore tend to develop hyperactive immune systems incapable of differentiating harmless substances from the harmful substances. Food allergies especially in children has doubled and one the reasons is the overuse of antibiotics and other drugs that reduce acid production in the stomach. This alters the behavior and function of the gastrointestinal tract inducing allergic reactions to food. Also, delayed introduction of certain foods in babies is also a key factor for developing food allergies later in life. Studies have revealed that over 25% of toddlers not introduced to peanuts in their diet go on to develop peanut allergy. Few of the common food allergies include eggs, tree nuts, peanuts, shellfish, wheat, soy, fish, among others. Vitamin D hypothesis associates deficiency or hypovitaminosis D with increased asthma and allergic rhinitis prevalence. New studies are revealing insights into the pleiotropic effects of vitamin D. Vitamin D is increasingly being recognized as an immunomodulator and its supplementation is gaining prominence in the treatment of allergic diseases. The most interesting of the reasons put forward for the prevalence of allergies is the hidden Neanderthal DNA present in modern humans. Inter-species breeding between modern humans and ape-like species called the Neanderthals and Denisovans about 50,000 years ago is believed to be responsible for our susceptibility to allergies by influencing the genetic diversity in present-day immunity genes belonging to the human Toll-like-receptor (TLRs) family. All humans today carry trace amounts of Neanderthal DNA in the range of 1% to 6%.

Whatever maybe the reason for the rise in allergies, the scenario is throwing the spotlight on the state of allergy care worldwide, which continues to be chronically under-resourced, under-supplied with high unmet diagnostic and treatment needs. Allergy diagnostics and treatment are therefore expected to witness robust untapped potential for growth with the need of the hour being a holistic integrated approach to allergy management. The robust commercial rewards, in this space, will induce more intensive R&D for the development of non-invasive, painless, needle free allergy testing and screening methods. While the skin prick test remains popular and widespread, companies are developing innovative pain and scar-free alternatives such as single drop blood tests. The mast cell activation test (MAT) which uses blood (serum) is an example in this space. Rising in prominence is "molecular allergology" aimed at more accurately identifying and managing IgE-mediated allergic reactions and disorders like allergic respiratory diseases, food allergies, and anaphylaxis. Growth in the market hinges on the progress made in quantifying and benchmarking specific IgE responsible for the allergy. Specific IgE testing has the benefit of providing valuable diagnostic and prognostic information on serious allergies. AllerGenis LLC has broken new grounds in the long-stagnant allergy diagnostics market with its proprietary Luminex`s bead-based xMAP® technology capable of isolating allergenic proteins into smaller peptides called epitopes for easy identification. The United States and Europe represent large markets worldwide with a combined share of 60.7% of the market. China ranks as the fastest growing market with a CAGR of 15% over the analysis period supported by rising rates of skin allergies and high number of misdiagnosis of food allergies due to imprecise tests.


Read the full report: https://www.reportlinker.com/p05797875/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Allergens: A Prelude
Key Allergy Stats
Allergy: Symptoms and Causes
Global Allergy Diagnostics Market Set to Witness Rapid Growth
With Allergies on the Rise for Whatever Reason Be It Our
Neanderthal Genes or Hygiene Hypothesis or Vitamin D
Hypothesis, the Need for Effective Diagnostics Has Never Been
Greater
Global Prevalence of Allergies (In Million)
Assay Kits Dominate the Allergy Diagnostics Market
Inhaled Allergens Segment to Witness Fastest Growth
US Dominates the Allergy Diagnostics Market, While China to
Witness the Fastest Growth
World Allergy Diagnostics Market by Region (2019 & 2025):
Percentage Breakdown of Dollar Sales for Developed and
Developing Regions
World Allergy Diagnostics Market - Geographic Regions Ranked by
Volume CAGR for 2018-2025: China, Asia-Pacific, Latin America,
Middle East, Canada, USA, Africa, Europe, and Japan
Rising Demand for In-Vitro Diagnostic Tests for Allergy Diagnosis
Global In-Vitro Diagnostics (IVD) Market Revenues (in %) by
Segment for the Year 2019
Global In-Vitro Diagnostics (IVD) Market Revenues (in %) by
Geographic Region for the Year 2019
Impact of Covid-19 and a Looming Global Recession
Competitive Landscape
Allergy Diagnostics Competitor Market Share Scenario Worldwide
(in %): 2019

2. FOCUS ON SELECT PLAYERS
Alk-Abello A/S (Denmark)
Allergy Therapeutics PLC (UK)
Angsana Molecular & Diagnostics Laboratory Pte. Ltd. (Singapore)
Astra Biotech Gmbh (Germany)
biomerieux SA (France)
Danaher Corporation (USA)
Demeditec Diagnostics GmbH (Germany)
EUROIMMUN AG (Germany)
GA Generic Assays GmbH (Germany)
Hitachi Chemical Co., Ltd. (Japan)
INDOOR Biotechnologies, Inc. (USA)
Lincoln Diagnostics, Inc. (USA)
Omega Diagnostics Group Plc (UK)
R-Biopharm Ag (Germany)
Roxall Medizin GmbH (Germany)
Stallergenes Greer (UK)
Siemens Healthineers (Germany)
Tecan Trading AG (Switzerland)
Theradiag (France)
Thermo Fisher Scientific Inc. (USA)

3. MARKET TRENDS & DRIVERS
Development of Effective Allergy Diagnostic Products Cuts Down
on Healthcare Spending
World Healthcare Expenditure (In US$ Trillion) for the Years
2017, 2019, 2021 & 2023
Per Capita Healthcare Expenditure (in $) by Select Countries
for 2018
Labs Embrace Automation and Advanced Allergy Tests for Fast
Turnaround Times
Need to Offer Quality Services at Affordable Costs Prompts Labs
to Consider Reagent Rental Agreements
In-Vitro IgE Molecular Diagnostics to Transform Allergy Testing
Market
Macro Array Diagnostics Unveils Allergy Explorer for Allergy
Diagnostics
Rising Alcohol and Drug Abuse Increases Demand for Allergy
Diagnostics
Increasing Cases of Allergies Drive Development of Advanced
Allergy Diagnostics Solutions
Focus on Single and Protein Allergens
IgE Antibody Tests
Allergy Diagnostic Reagents on Microchip
Allergy Diagnosis Moves from Lab-based to Decentralized POC Tests
Patch Test to Experience Healthy Growth
SmartPractice Secures FDA Approval for T.R.U.E. Test(R) Patch
Test for Pediatric Use
Providers of Allergy Diagnostic Services Focus on Vertical
Integration
Allergic Diagnostic Challenges in Patients
Enhanced Access to Allergy Diagnosis Medical Insurance &
Instrument Allowances in the US Widen Market Prospects
Typical Cost Structure for Allergy Testing
Select Digital Technologies to Provide Help in Managing Food
Allergy
Select Recent Launches in the Allergy Diagnostics Market to
Bolster Market Expansion
EUROIMMUM Develops EUROLINE DPA-Dx Pollen Southern Europe 1
Test for Pollen Allergies
Hycor Biomedical Secures FDA Clearance for NOVEOS Allergy
Testing System
ASI Introduces IVT Allergy(R) 3 Screen Panel for Allergy Skin
Testing
CLA-1(TM) Luminometer In-Vitro Allergy Testing Platform for
Accurate, Reliable Results
Growth Drivers
Increasing Prevalence and Incidence of Allergic Disorders to
Drive the Demand for Allergy Diagnostics
Atopic Dermatitis (Eczema) Prevalence Rates among Global Adult
Population
Environmental Changes and Pollution Aggravate Incidence of
Allergic Reactions, Resulting in Increased Need for Allergy
Diagnostics
Major Environmental Factors with Link to Allergic Diseases
Growing Number of Food Allergy Cases Fuels Demand for Allergy
Testing Kits
Prevalence Rate of Five Common Food Allergies among US Adults
Factors Responsible for Rising Prevalence of Food Allergy
Burgeoning Aging Population and Longer Life Expectancy to Drive
Allergy Diagnostics Market
Global Population Statistics for the 65+ Age Group in Million
by Geographic Region for the Years 2019, 2025, 2035 and 2050
Market Restraints
Inadequate Knowledge about Food Allergy Inhibits Growth of
Allergy Diagnostic Market
Expensive Nature of Allergy Diagnostics Approaches Limits
Market Growth
New Regulations and Statutory Provisions to Affect Diagnostic
Allergen Extracts

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Allergy
Diagnostics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2020 through 2027

Table 2: World Historic Review for Allergy Diagnostics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 3: World 15-Year Perspective for Allergy Diagnostics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Assay Kits by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 5: World Historic Review for Assay Kits by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2019

Table 6: World 15-Year Perspective for Assay Kits by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 8: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2019

Table 9: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 11: World Historic Review for Services by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2019

Table 12: World 15-Year Perspective for Services by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Inhaled Allergens
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 14: World Historic Review for Inhaled Allergens by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 15: World 15-Year Perspective for Inhaled Allergens by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Food Allergens by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 17: World Historic Review for Food Allergens by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 18: World 15-Year Perspective for Food Allergens by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Drug Allergens by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 20: World Historic Review for Drug Allergens by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 21: World 15-Year Perspective for Drug Allergens by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Other Allergens
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 23: World Historic Review for Other Allergens by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 24: World 15-Year Perspective for Other Allergens by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Hospital by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 26: World Historic Review for Hospital by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2019

Table 27: World 15-Year Perspective for Hospital by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Diagnostic
Laboratory by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2020 through 2027

Table 29: World Historic Review for Diagnostic Laboratory by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 30: World 15-Year Perspective for Diagnostic Laboratory
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2020 through 2027

Table 32: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 33: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
Allergy Prevalence Statistics
Incidences of Food Allergy and Intolerance on the Rise among
Americans
Pain Killer Abuse Leads to High Incident of Drug Allergy Reactions
US Witnesses Increasing Popularity of At-Home Allergy
Diagnostic Kits
US Offers Favorable Reimbursements for Allergy Testing
Market Analytics
Table 34: USA Current & Future Analysis for Allergy Diagnostics
by Product - Assay Kits, Instruments and Services - Independent
Analysis of Annual Sales in US$ Billion for the Years 2020
through 2027

Table 35: USA Historic Review for Allergy Diagnostics by
Product - Assay Kits, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 36: USA 15-Year Perspective for Allergy Diagnostics by
Product - Percentage Breakdown of Value Sales for Assay Kits,
Instruments and Services for the Years 2012, 2020 & 2027

Table 37: USA Current & Future Analysis for Allergy Diagnostics
by Allergens - Inhaled Allergens, Food Allergens, Drug
Allergens and Other Allergens - Independent Analysis of Annual
Sales in US$ Billion for the Years 2020 through 2027

Table 38: USA Historic Review for Allergy Diagnostics by
Allergens - Inhaled Allergens, Food Allergens, Drug Allergens
and Other Allergens Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 39: USA 15-Year Perspective for Allergy Diagnostics by
Allergens - Percentage Breakdown of Value Sales for Inhaled
Allergens, Food Allergens, Drug Allergens and Other Allergens
for the Years 2012, 2020 & 2027

Table 40: USA Current & Future Analysis for Allergy Diagnostics
by End-Use - Hospital, Diagnostic Laboratory and Other End-Uses -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2020 through 2027

Table 41: USA Historic Review for Allergy Diagnostics by
End-Use - Hospital, Diagnostic Laboratory and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2019

Table 42: USA 15-Year Perspective for Allergy Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospital,
Diagnostic Laboratory and Other End-Uses for the Years 2012,
2020 & 2027

CANADA
Table 43: Canada Current & Future Analysis for Allergy
Diagnostics by Product - Assay Kits, Instruments and Services -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2020 through 2027

Table 44: Canada Historic Review for Allergy Diagnostics by
Product - Assay Kits, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 45: Canada 15-Year Perspective for Allergy Diagnostics by
Product - Percentage Breakdown of Value Sales for Assay Kits,
Instruments and Services for the Years 2012, 2020 & 2027

Table 46: Canada Current & Future Analysis for Allergy
Diagnostics by Allergens - Inhaled Allergens, Food Allergens,
Drug Allergens and Other Allergens - Independent Analysis of
Annual Sales in US$ Billion for the Years 2020 through 2027

Table 47: Canada Historic Review for Allergy Diagnostics by
Allergens - Inhaled Allergens, Food Allergens, Drug Allergens
and Other Allergens Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 48: Canada 15-Year Perspective for Allergy Diagnostics by
Allergens - Percentage Breakdown of Value Sales for Inhaled
Allergens, Food Allergens, Drug Allergens and Other Allergens
for the Years 2012, 2020 & 2027

Table 49: Canada Current & Future Analysis for Allergy
Diagnostics by End-Use - Hospital, Diagnostic Laboratory and
Other End-Uses - Independent Analysis of Annual Sales in US$
Billion for the Years 2020 through 2027

Table 50: Canada Historic Review for Allergy Diagnostics by
End-Use - Hospital, Diagnostic Laboratory and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2019

Table 51: Canada 15-Year Perspective for Allergy Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospital,
Diagnostic Laboratory and Other End-Uses for the Years 2012,
2020 & 2027

JAPAN
Table 52: Japan Current & Future Analysis for Allergy
Diagnostics by Product - Assay Kits, Instruments and Services -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2020 through 2027

Table 53: Japan Historic Review for Allergy Diagnostics by
Product - Assay Kits, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 54: Japan 15-Year Perspective for Allergy Diagnostics by
Product - Percentage Breakdown of Value Sales for Assay Kits,
Instruments and Services for the Years 2012, 2020 & 2027

Table 55: Japan Current & Future Analysis for Allergy
Diagnostics by Allergens - Inhaled Allergens, Food Allergens,
Drug Allergens and Other Allergens - Independent Analysis of
Annual Sales in US$ Billion for the Years 2020 through 2027

Table 56: Japan Historic Review for Allergy Diagnostics by
Allergens - Inhaled Allergens, Food Allergens, Drug Allergens
and Other Allergens Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 57: Japan 15-Year Perspective for Allergy Diagnostics by
Allergens - Percentage Breakdown of Value Sales for Inhaled
Allergens, Food Allergens, Drug Allergens and Other Allergens
for the Years 2012, 2020 & 2027

Table 58: Japan Current & Future Analysis for Allergy
Diagnostics by End-Use - Hospital, Diagnostic Laboratory and
Other End-Uses - Independent Analysis of Annual Sales in US$
Billion for the Years 2020 through 2027

Table 59: Japan Historic Review for Allergy Diagnostics by
End-Use - Hospital, Diagnostic Laboratory and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2019

Table 60: Japan 15-Year Perspective for Allergy Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospital,
Diagnostic Laboratory and Other End-Uses for the Years 2012,
2020 & 2027

CHINA
Table 61: China Current & Future Analysis for Allergy
Diagnostics by Product - Assay Kits, Instruments and Services -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2020 through 2027

Table 62: China Historic Review for Allergy Diagnostics by
Product - Assay Kits, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 63: China 15-Year Perspective for Allergy Diagnostics by
Product - Percentage Breakdown of Value Sales for Assay Kits,
Instruments and Services for the Years 2012, 2020 & 2027

Table 64: China Current & Future Analysis for Allergy
Diagnostics by Allergens - Inhaled Allergens, Food Allergens,
Drug Allergens and Other Allergens - Independent Analysis of
Annual Sales in US$ Billion for the Years 2020 through 2027

Table 65: China Historic Review for Allergy Diagnostics by
Allergens - Inhaled Allergens, Food Allergens, Drug Allergens
and Other Allergens Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 66: China 15-Year Perspective for Allergy Diagnostics by
Allergens - Percentage Breakdown of Value Sales for Inhaled
Allergens, Food Allergens, Drug Allergens and Other Allergens
for the Years 2012, 2020 & 2027

Table 67: China Current & Future Analysis for Allergy
Diagnostics by End-Use - Hospital, Diagnostic Laboratory and
Other End-Uses - Independent Analysis of Annual Sales in US$
Billion for the Years 2020 through 2027

Table 68: China Historic Review for Allergy Diagnostics by
End-Use - Hospital, Diagnostic Laboratory and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2019

Table 69: China 15-Year Perspective for Allergy Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospital,
Diagnostic Laboratory and Other End-Uses for the Years 2012,
2020 & 2027

EUROPE
Market Facts & Figures
Food Allergy: Regulatory Overview
EU FIC Regulation
Soy Allergy Regulations
Egg Allergy Regulations
Market Analytics
Table 70: Europe Current & Future Analysis for Allergy
Diagnostics by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2020 through 2027

Table 71: Europe Historic Review for Allergy Diagnostics by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 72: Europe 15-Year Perspective for Allergy Diagnostics by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Allergy
Diagnostics by Product - Assay Kits, Instruments and Services -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2020 through 2027

Table 74: Europe Historic Review for Allergy Diagnostics by
Product - Assay Kits, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 75: Europe 15-Year Perspective for Allergy Diagnostics by
Product - Percentage Breakdown of Value Sales for Assay Kits,
Instruments and Services for the Years 2012, 2020 & 2027

Table 76: Europe Current & Future Analysis for Allergy
Diagnostics by Allergens - Inhaled Allergens, Food Allergens,
Drug Allergens and Other Allergens - Independent Analysis of
Annual Sales in US$ Billion for the Years 2020 through 2027

Table 77: Europe Historic Review for Allergy Diagnostics by
Allergens - Inhaled Allergens, Food Allergens, Drug Allergens
and Other Allergens Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 78: Europe 15-Year Perspective for Allergy Diagnostics by
Allergens - Percentage Breakdown of Value Sales for Inhaled
Allergens, Food Allergens, Drug Allergens and Other Allergens
for the Years 2012, 2020 & 2027

Table 79: Europe Current & Future Analysis for Allergy
Diagnostics by End-Use - Hospital, Diagnostic Laboratory and
Other End-Uses - Independent Analysis of Annual Sales in US$
Billion for the Years 2020 through 2027

Table 80: Europe Historic Review for Allergy Diagnostics by
End-Use - Hospital, Diagnostic Laboratory and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2019

Table 81: Europe 15-Year Perspective for Allergy Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospital,
Diagnostic Laboratory and Other End-Uses for the Years 2012,
2020 & 2027

FRANCE
Table 82: France Current & Future Analysis for Allergy
Diagnostics by Product - Assay Kits, Instruments and Services -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2020 through 2027

Table 83: France Historic Review for Allergy Diagnostics by
Product - Assay Kits, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 84: France 15-Year Perspective for Allergy Diagnostics by
Product - Percentage Breakdown of Value Sales for Assay Kits,
Instruments and Services for the Years 2012, 2020 & 2027

Table 85: France Current & Future Analysis for Allergy
Diagnostics by Allergens - Inhaled Allergens, Food Allergens,
Drug Allergens and Other Allergens - Independent Analysis of
Annual Sales in US$ Billion for the Years 2020 through 2027

Table 86: France Historic Review for Allergy Diagnostics by
Allergens - Inhaled Allergens, Food Allergens, Drug Allergens
and Other Allergens Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 87: France 15-Year Perspective for Allergy Diagnostics by
Allergens - Percentage Breakdown of Value Sales for Inhaled
Allergens, Food Allergens, Drug Allergens and Other Allergens
for the Years 2012, 2020 & 2027

Table 88: France Current & Future Analysis for Allergy
Diagnostics by End-Use - Hospital, Diagnostic Laboratory and
Other End-Uses - Independent Analysis of Annual Sales in US$
Billion for the Years 2020 through 2027

Table 89: France Historic Review for Allergy Diagnostics by
End-Use - Hospital, Diagnostic Laboratory and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2019

Table 90: France 15-Year Perspective for Allergy Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospital,
Diagnostic Laboratory and Other End-Uses for the Years 2012,
2020 & 2027

GERMANY
Table 91: Germany Current & Future Analysis for Allergy
Diagnostics by Product - Assay Kits, Instruments and Services -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2020 through 2027

Table 92: Germany Historic Review for Allergy Diagnostics by
Product - Assay Kits, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 93: Germany 15-Year Perspective for Allergy Diagnostics
by Product - Percentage Breakdown of Value Sales for Assay
Kits, Instruments and Services for the Years 2012, 2020 & 2027

Table 94: Germany Current & Future Analysis for Allergy
Diagnostics by Allergens - Inhaled Allergens, Food Allergens,
Drug Allergens and Other Allergens - Independent Analysis of
Annual Sales in US$ Billion for the Years 2020 through 2027

Table 95: Germany Historic Review for Allergy Diagnostics by
Allergens - Inhaled Allergens, Food Allergens, Drug Allergens
and Other Allergens Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 96: Germany 15-Year Perspective for Allergy Diagnostics
by Allergens - Percentage Breakdown of Value Sales for Inhaled
Allergens, Food Allergens, Drug Allergens and Other Allergens
for the Years 2012, 2020 & 2027

Table 97: Germany Current & Future Analysis for Allergy
Diagnostics by End-Use - Hospital, Diagnostic Laboratory and
Other End-Uses - Independent Analysis of Annual Sales in US$
Billion for the Years 2020 through 2027

Table 98: Germany Historic Review for Allergy Diagnostics by
End-Use - Hospital, Diagnostic Laboratory and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2019

Table 99: Germany 15-Year Perspective for Allergy Diagnostics
by End-Use - Percentage Breakdown of Value Sales for Hospital,
Diagnostic Laboratory and Other End-Uses for the Years 2012,
2020 & 2027

ITALY
Table 100: Italy Current & Future Analysis for Allergy
Diagnostics by Product - Assay Kits, Instruments and Services -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2020 through 2027

Table 101: Italy Historic Review for Allergy Diagnostics by
Product - Assay Kits, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 102: Italy 15-Year Perspective for Allergy Diagnostics by
Product - Percentage Breakdown of Value Sales for Assay Kits,
Instruments and Services for the Years 2012, 2020 & 2027

Table 103: Italy Current & Future Analysis for Allergy
Diagnostics by Allergens - Inhaled Allergens, Food Allergens,
Drug Allergens and Other Allergens - Independent Analysis of
Annual Sales in US$ Billion for the Years 2020 through 2027

Table 104: Italy Historic Review for Allergy Diagnostics by
Allergens - Inhaled Allergens, Food Allergens, Drug Allergens
and Other Allergens Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 105: Italy 15-Year Perspective for Allergy Diagnostics by
Allergens - Percentage Breakdown of Value Sales for Inhaled
Allergens, Food Allergens, Drug Allergens and Other Allergens
for the Years 2012, 2020 & 2027

Table 106: Italy Current & Future Analysis for Allergy
Diagnostics by End-Use - Hospital, Diagnostic Laboratory and
Other End-Uses - Independent Analysis of Annual Sales in US$
Billion for the Years 2020 through 2027

Table 107: Italy Historic Review for Allergy Diagnostics by
End-Use - Hospital, Diagnostic Laboratory and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2019

Table 108: Italy 15-Year Perspective for Allergy Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospital,
Diagnostic Laboratory and Other End-Uses for the Years 2012,
2020 & 2027

UNITED KINGDOM
Table 109: UK Current & Future Analysis for Allergy Diagnostics
by Product - Assay Kits, Instruments and Services - Independent
Analysis of Annual Sales in US$ Billion for the Years 2020
through 2027

Table 110: UK Historic Review for Allergy Diagnostics by
Product - Assay Kits, Instruments and Services Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2019

Table 111: UK 15-Year Perspective for Allergy Diagnostics by
Product - Percentage Breakdown of Value Sales for Assay Kits,
Instruments and Services for the Years 2012, 2020 & 2027

Table 112: UK Current & Future Analysis for Allergy Diagnostics
by Allergens - Inhaled Allergens, Food Allergens, Drug
Allergens and Other Allergens - Independent Analysis of Annual
Sales in US$ Billion for the Years 2020 through 2027

Table 113: UK Historic Review for Allergy Diagnostics by
Allergens - Inhaled Allergens, Food Allergens, Drug Allergens
and Other Allergens Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2019

Table 114: UK 15-Year Perspective for Allergy Diagnostics by
Allergens - Percentage Breakdown of Value Sales for Inhaled
Allergens, Food Allergens, Drug Allergens and Other Allergens
for the Years 2012, 2020 & 2027

Table 115: UK Current & Future Analysis for Allergy Diagnostics
by End-Use - Hospital, Diagnostic Laboratory and Other End-Uses -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2020 through 2027

Table 116: UK Historic Review for Allergy Diagnostics by
End-Use - Hospital, Diagnostic Laboratory and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Billion
for Years 2012 through 2019

Table 117: UK 15-Year Perspective for Allergy Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospital,
Diagnostic Laboratory and Other End-Uses for the Years 2012,
2020 & 2027

SPAIN
Table 118: Spain Current & Future Analysis for Allergy
Diagnostics by Product - Assay Kits, Instruments and Services -

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05797875/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

 

            











    

        

        
Contact Data